At RayzeBio, we get it done. Every patient deserves access to the best possible treatment, and we’re committed to making a difference in the lives of people with cancer. Radiopharmaceutical therapy is positioned to revolutionize the treatment of cancer – RayzeBio, a Bristol Myers Squibb Company – is committed to advancing radiopharmaceutical therapies through the clinic and to more patients to change lives.
With a history rooted in biotech, now part of the best-in-class capabilities of Bristol Myers Squibb, we are harnessing the power of targeted radioisotopes to focus on improving survival of people living with cancer.
